Systematic Optimization, In Vitro Drug Release, and Preliminary Nonclinical Toxicity Assessment of Nonphospholipid-Based Topical Ophthalmic Emulsions Containing 0.05 or 0.1% w/w Cyclosporin A for Dry-Eye Syndrome Management-Reference-Cited by-同舟云学术

Systematic Optimization, In Vitro Drug Release, and Preliminary Nonclinical Toxicity Assessment of Nonphospholipid-Based Topical Ophthalmic Emulsions Containing 0.05 or 0.1% w/w Cyclosporin A for Dry-Eye Syndrome Management

Published:2019-12-26 Issue:2 Volume:21 Page:
ISSN:1530-9932
Container-title:AAPS PharmSciTech
language:en
Short-container-title:AAPS PharmSciTech

Author:

Rahman Syed Nazrin Ruhina,Pawde Datta Maroti,Katari Oly,Hmingthansanga Victor,Shunmugaperumal Tamilvanan^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics

Link

http://link.springer.com/content/pdf/10.1208/s12249-019-1587-5.pdf

Reference25 articles.

1. . Q8(R2) pharmaceutical development. Part I: pharmaceutical development, and Part II: annex to pharmaceutical development. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf (2009). Accessed date 1 Aug 2019.

2. ICH. Q9 quality risk management. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q9/Step4/Q9_Guideline.pdf (2005). Accessed date1 Aug 2019.

3. ICH. Q10 pharmaceutical quality system. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q10/Step4/Q10_Guideline.pdf (2008). Accessed date 1 Aug 2019.

4. Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol. 2004;137:337–42.

5. Fruman DA, Klee CB, Bierer BE, Burakoff SJ. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A. 1992;89:3686–90.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intratympanic injections of emulsion-like dispersions to augment cinnarizine amount in a healthy rabbit inner ear model;Nanomedicine;2024-07-23

2. Studies on cationic ocular emulsions containing bipartitioned oil droplets to codeliver cyclosporin A and etodolac;Nanomedicine;2024-04-30

3. From co-delivery to synergistic anti-inflammatory effect: Studies on chitosan-stabilized Janus emulsions having chloroquine phosphate and flavopiridol in Complete Freund's Adjuvant induced arthritis rat model;International Journal of Biological Macromolecules;2024-02

4. Intriguing of pharmaceutical product development processes with the help of artificial intelligence and deep/machine learning or artificial neural network;Journal of Drug Delivery Science and Technology;2023-09

5. Development and In-vitro Evaluation of Dexamethasone Enriched Nanoemulsion for Ophthalmic Indication;Drug Delivery Letters;2023-09